As of October 16, 2026, PTC Therapeutics had a market cap of $4.936 billion, which decreased by 2.87% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.
Data updated: Oct 16, 2026, 4:00 PM ET
PTC Therapeutics, Inc. (PTCT)
🌍 United States📈 NASDAQ🏭 Health Care🏢 Biotechnology
Note: Each point on the chart represents the market capitalization at the end of the trading day. Source: Data compiled from
EDGAR filings,
Bloomberg
and Yahoo Finance.
📈 PTC Therapeutics Market Cap History by Year and Month
PTC Therapeutics Market Cap History by Year and Month
Year / Month
Market Cap
% Change
2026
$4.936B
▼ 19.07%
$4.936B
▼ 8.56%
$5.398B
▼ 6.85%
$5.795B
▲ 2.80%
$5.637B
▼ 16.62%
$6.761B
▲ 10.37%
$6.126B
▲ 13.76%
$5.385B
▼ 4.50%
$5.639B
▲ 3.00%
$5.475B
▼ 9.71%
$6.064B
▼ 0.57%
2025
$6.099B
▲ 73.91%
$6.099B
▼ 11.66%
$6.904B
▲ 26.45%
$5.46B
▲ 11.31%
$4.905B
▲ 25.16%
$3.919B
▼ 5.25%
$4.136B
▲ 6.68%
$3.877B
▲ 0.81%
$3.846B
▼ 2.61%
$3.949B
▼ 2.20%
$4.038B
▼ 7.34%
$4.358B
▲ 22.24%
$3.565B
▲ 1.65%
2024
$3.507B
▲ 68.61%
$3.507B
▲ 3.63%
$3.384B
▲ 10.16%
$3.072B
▲ 7.60%
$2.855B
▲ 5.08%
$2.717B
▲ 4.38%
$2.603B
▲ 11.00%
$2.345B
▼ 15.92%
$2.789B
▲ 13.10%
$2.466B
▲ 10.63%
$2.229B
▲ 3.19%
$2.16B
▲ 9.37%
$1.975B
▼ 5.05%
2023
$2.08B
▼ 25.34%
$2.08B
▲ 19.75%
$1.737B
▲ 22.76%
$1.415B
▼ 16.17%
$1.688B
▼ 43.28%
$2.976B
▼ 2.04%
$3.038B
▼ 0.82%
$3.063B
▼ 1.64%
$3.114B
▼ 23.88%
$4.091B
▲ 14.11%
$3.585B
▲ 11.20%
$3.224B
▼ 3.90%
$3.355B
▲ 20.42%
2022
$2.786B
▼ 1.24%
$2.786B
▼ 7.99%
$3.028B
▲ 9.71%
$2.76B
▼ 23.48%
$3.607B
▲ 0.95%
$3.573B
▲ 14.74%
$3.114B
▲ 8.69%
$2.865B
▲ 36.75%
$2.095B
▼ 16.90%
$2.521B
▼ 5.30%
$2.662B
▲ 6.23%
$2.506B
▼ 12.04%
$2.849B
▲ 0.99%
2021
$2.821B
▼ 33.70%
$2.821B
▲ 7.38%
$2.627B
▼ 2.05%
$2.682B
▲ 2.02%
$2.629B
▼ 14.70%
$3.082B
▲ 13.90%
$2.706B
▼ 9.29%
$2.983B
▲ 7.81%
$2.767B
▼ 4.65%
$2.902B
▼ 12.96%
$3.334B
▼ 16.96%
$4.015B
▼ 0.40%
$4.031B
▼ 5.26%
2020
$4.255B
▲ 43.03%
$4.255B
▼ 0.35%
$4.27B
▲ 19.91%
$3.561B
▲ 12.33%
$3.17B
▼ 5.26%
$3.346B
▲ 7.42%
$3.115B
▼ 8.70%
$3.412B
▲ 2.55%
$3.327B
▼ 0.39%
$3.34B
▲ 19.29%
$2.8B
▼ 18.49%
$3.435B
▲ 7.68%
$3.19B
▲ 7.23%
2019
$2.975B
▲ 71.27%
$2.975B
▲ 2.80%
$2.894B
▲ 14.84%
$2.52B
▲ 20.98%
$2.083B
▼ 20.71%
$2.627B
▼ 7.50%
$2.84B
▲ 8.03%
$2.629B
▲ 12.21%
$2.343B
▲ 7.18%
$2.186B
▼ 0.55%
$2.198B
▲ 8.97%
$2.017B
▲ 11.07%
$1.816B
▲ 4.55%
2018
$1.737B
▲ 151.01%
$1.737B
▼ 3.07%
$1.792B
▼ 7.77%
$1.943B
▼ 17.67%
$2.36B
▲ 12.60%
$2.096B
▲ 17.89%
$1.778B
▲ 13.47%
$1.567B
▼ 0.51%
$1.575B
▲ 22.38%
$1.287B
▲ 13.79%
$1.131B
▲ 5.11%
$1.076B
▼ 1.65%
$1.094B
▲ 58.09%
2017
$0.692B
▲ 85.03%
$0.692B
▲ 4.53%
$0.662B
▼ 14.91%
$0.778B
▼ 6.04%
$0.828B
▼ 3.61%
$0.859B
▲ 0.82%
$0.852B
▲ 12.55%
$0.757B
▲ 46.42%
$0.517B
▲ 3.19%
$0.501B
▲ 48.22%
$0.338B
▼ 28.24%
$0.471B
▲ 5.13%
$0.448B
▲ 19.79%
2016
$0.374B
▼ 66.31%
$0.374B
▼ 2.09%
$0.382B
▲ 80.19%
$0.212B
▼ 55.74%
$0.479B
▲ 70.46%
$0.281B
▲ 38.42%
$0.203B
▼ 15.06%
$0.239B
▼ 14.64%
$0.28B
▲ 10.24%
$0.254B
▲ 16.51%
$0.218B
▼ 20.15%
$0.273B
▼ 66.54%
$0.816B
▼ 26.49%
2015
$1.11B
▼ 34.82%
$1.11B
▲ 7.87%
$1.029B
▲ 20.77%
$0.852B
▼ 6.89%
$0.915B
▼ 30.10%
$1.309B
▼ 25.41%
$1.755B
▲ 7.67%
$1.63B
▼ 17.09%
$1.966B
▼ 1.16%
$1.989B
▼ 2.36%
$2.037B
▼ 15.23%
$2.403B
▲ 32.98%
$1.807B
▲ 6.11%
2014
$1.703B
▲ 321.53%
$1.703B
▲ 13.23%
$1.504B
▲ 25.33%
$1.2B
▼ 7.19%
$1.293B
▲ 35.82%
$0.952B
▲ 19.90%
$0.794B
▲ 1.02%
$0.786B
▲ 10.24%
$0.713B
▲ 21.26%
$0.588B
▼ 25.19%
$0.786B
▲ 5.36%
$0.746B
▲ 20.32%
$0.62B
▲ 53.47%
2013
$0.404B
▲ 3.59%
$0.404B
▲ 8.31%
$0.373B
▼ 13.05%
$0.429B
▼ 16.05%
$0.511B
▲ 19.67%
$0.427B
▲ 14.48%
$0.373B
▲ 5.07%
$0.355B
▼ 8.97%
All market cap values reflect closing prices for the period shown.
📊 PTC Therapeutics Market Cap and Other Industry Peers
Below are selected companies from the Biotechnology sector / subsector: